ProfileGDS4718 / 225676_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 77% 85% 82% 82% 96% 97% 86% 81% 87% 89% 81% 96% 98% 95% 90% 87% 97% 94% 89% 86% 85% 85% 86% 88% 97% 84% 95% 84% 95% 92% 93% 76% 85% 97% 93% 96% 87% 83% 83% 87% 96% 89% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9261788
GSM549102patient 115, normal, homogenized [OPG study]7.4416877
GSM549104patient 119, normal, homogenized [OPG study]8.4943685
GSM549108patient 138, normal, homogenized [OPG study]8.0027382
GSM549119patient 077, normal, homogenized [OPG study]8.067782
GSM549133patient 032, cancer, homogenized [OPG study]10.684296
GSM549139patient 042, cancer, homogenized [OPG study]10.771997
GSM549099patient 107, normal, homogenized [OPG study]8.5241386
GSM549109patient 139, normal, homogenized [OPG study]7.9322881
GSM549110patient 046, normal, homogenized [OPG study]8.6854187
GSM549114patient 063, normal, homogenized [OPG study]9.2597189
GSM549122patient 082, normal, homogenized [OPG study]7.9142881
GSM549134patient 033, cancer, homogenized [OPG study]10.583496
GSM549136patient 036, cancer, homogenized [OPG study]11.333498
GSM549140patient 044, cancer, homogenized [OPG study]10.283895
GSM549111patient 047, normal, homogenized [OPG study]9.2524490
GSM549113patient 057, normal, homogenized [OPG study]8.9499487
GSM549132patient 031, cancer, homogenized [OPG study]10.771397
GSM549137patient 038, cancer, homogenized [OPG study]9.9665294
GSM549142patient 047, cancer, homogenized [OPG study]8.6052789
GSM549100patient 110, normal, homogenized [OPG study]8.5451786
GSM549107patient 135, normal, homogenized [OPG study]8.5256385
GSM549115patient 068, normal, homogenized [OPG study]8.6308885
GSM549116patient 072, normal, homogenized [OPG study]8.6708286
GSM549120patient 078, normal, homogenized [OPG study]8.8287888
GSM549131patient 030, cancer, homogenized [OPG study]11.047697
GSM549118patient 074, normal, homogenized [OPG study]8.4327384
GSM549129patient 027, cancer, homogenized [OPG study]9.9937795
GSM549123patient 088, normal, homogenized [OPG study]8.3363384
GSM549124patient 006, cancer, homogenized [OPG study]10.084795
GSM549126patient 015, cancer, homogenized [OPG study]9.4003192
GSM549128patient 025, cancer, homogenized [OPG study]9.8293493
GSM549103patient 117, normal, homogenized [OPG study]7.2909976
GSM549117patient 073, normal, homogenized [OPG study]8.5546785
GSM549138patient 041, cancer, homogenized [OPG study]10.853897
GSM549141patient 045, cancer, homogenized [OPG study]9.8276193
GSM549130patient 028, cancer, homogenized [OPG study]10.375996
GSM549101patient 111, normal, homogenized [OPG study]8.7389387
GSM549105patient 128, normal, homogenized [OPG study]8.1522383
GSM549106patient 134, normal, homogenized [OPG study]8.4441183
GSM549112patient 048, normal, homogenized [OPG study]8.7896987
GSM549125patient 011, cancer, homogenized [OPG study]10.442296
GSM549127patient 024, cancer, homogenized [OPG study]8.9888289
GSM549135patient 035, cancer, homogenized [OPG study]10.942397